SEQUENTIAL ENDOLUMINAL GEMCITABINE AND CABAZITAXEL WITH SYSTEMIC PEMBROLIZUMAB FOR RECURRENT NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE UPPER AND LOWER URINARY TRACTS

被引:0
|
作者
McElree, Ian [1 ]
Steinberg, Ryan L. [1 ]
Mott, Sarah L. [1 ]
Packiam, Vignesh T. [1 ]
O'Donnell, Michael A. [1 ]
机构
[1] Univ Iowa, Iowa City, IA 52242 USA
关键词
D O I
10.1016/j.urolonc.2024.01.180
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
142
引用
收藏
页码:S61 / S62
页数:2
相关论文
共 50 条
  • [1] SEQUENTIAL ENDOLUMINAL CABAZITAXEL AND GEMCITABINE WITH PEMBROLIZUMAB FOR DOCETAXEL-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE UPPER AND LOWER URINARY TRACTS
    Packiam, Vignesh T.
    McElree, Ian
    Steinberg, Ryan L.
    Prescott, Adam
    Garje, Rohan
    Zakharia, Yousef
    O'Donnell, Michael A.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E489 - E490
  • [2] SEQUENTIAL ENDOLUMINAL DOXORUBICIN AND GEMCITABINE ALTERNATING WITH SEQUENTIAL MITOMYCIN AND DOCETAXEL FOR MULTI-FAILURE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE UPPER AND LOWER URINARY TRACTS
    Mcelree, Ian M.
    Steinberg, Ryan L.
    Sarah, L.
    Packiam, Vignesh T.
    O'Donnell, Michael A.
    JOURNAL OF UROLOGY, 2023, 209 : E873 - E874
  • [3] Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma
    Mcelree, Ian M.
    Packiam, Vignesh T.
    Steinberg, Ryan L.
    Hougen, Helen Y.
    Chakra, Mohamad Abou
    Mott, Sarah L.
    O'Donnell, Michael A.
    CANCERS, 2024, 16 (24)
  • [4] Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor
    McElree, Ian M.
    Packiam, Vignesh T.
    Steinberg, Ryan L.
    Hougen, Helen Y.
    Mott, Sarah L.
    Abou Chakra, Mohamad
    Zakharia, Yousef
    O'Donnell, Michael A.
    CANCERS, 2024, 16 (14)
  • [5] Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma
    Mcelree, Ian M.
    Belzer, Alex
    Mott, Sarah L.
    Packiam, Vignesh T.
    O'Donnell, Michael A.
    Steinberg, Ryan L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (01) : 20.e9 - 20.e15
  • [6] A phase II trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder
    DeCastro, G. J.
    Stein, M.
    Abate-Shen, C.
    Miles, C.
    Gray, J.
    Joffe, B.
    Anderson, C.
    Lenis, A.
    McKiernan, J. M. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1143 - S1143
  • [7] A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, G. Joel
    Anderson, Christopher
    Kates, Max
    Buckley-Matura, Bridget
    Sui, Wilson
    Lee, Shing M.
    Holder, Dara
    Virk, Renu
    Drake, Charles
    Abate-Shen, Cory
    McKiernan, James
    JOURNAL OF UROLOGY, 2019, 201 (04): : E623 - E623
  • [8] Phase 2 trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder.
    DeCastro, Guarionex Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    Gray, Jillian
    Ingram, Justin
    Stein, Mark N.
    McKiernan, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] RECURRENT NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA TUMORS HAVE COMMON ANCESTRAL CLONE
    Duymich, Christopher
    Syan-Bhanvadia, Sumeet
    Kim, Yong June
    Charlet, Jessica
    Yoon, Hung-Yoon
    Kim, Won Tae
    Kim, Wun-Jae
    Jones, Peter
    Daneshmand, Siamak
    Liang, Gangning
    JOURNAL OF UROLOGY, 2017, 197 (04): : E856 - E857
  • [10] Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma
    Kamada, Masayuki
    Koshikawa, Naohiko
    Minegishi, Tomoko
    Kawada, Chiaki
    Karashima, Takashi
    Shuin, Taro
    Seiki, Motoharu
    CANCER SCIENCE, 2015, 106 (12) : 1730 - 1737